StockNews.com Initiates Coverage on Can-Fite BioPharma (NYSE:CANF)
StockNews.com began coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a research report released on Sunday morning. The brokerage issued a hold rating on the stock. A number of other brokerages have also issued reports on CANF. HC Wainwright decreased their price target on Can-Fite BioPharma from $34.00 to $18.00 and set […]
More Stories
Salesforce (NYSE:CRM) Shares Down 0% on Insider Selling
Salesforce, Inc. (NYSE:CRM – Get Free Report) dropped 0% on Thursday after an insider sold shares in the company. The...
Ming Shing Group Holdings’ Lock-Up Period To End on May 21st (NASDAQ:MSW)
Ming Shing Group’s (NASDAQ:MSW – Get Free Report) lock-up period is set to end on Wednesday, May 21st. Ming Shing...
Enliven Therapeutics (NASDAQ:ELVN) Stock Price Down 7.6% Following Weak Earnings
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report)’s stock price fell 7.6% on Thursday following a dissappointing earnings announcement. The...
Dillard’s (NYSE:DDS) Trading 5.9% Higher on Strong Earnings
Dillard’s, Inc. (NYSE:DDS – Get Free Report) shares traded up 5.9% during trading on Thursday after the company announced better...
Liberty Latin America (NASDAQ:LILA) Shares Up 5.5% on Insider Buying Activity
Liberty Latin America Ltd. (NASDAQ:LILA – Get Free Report)’s stock price shot up 5.5% during trading on Thursday following insider...
Loar (NYSE:LOAR) Sees Large Volume Increase on Analyst Upgrade
Shares of Loar Holdings, LLC (NYSE:LOAR – Get Free Report) saw strong trading volume on Thursday after Citigroup raised their...